ESMO – immune cell-related biomarkers in metastatic HNSCC

ESMO shared on LinkedIn:

“Latest podcast. Annals of Oncology Editor in Chief Tom Powles talks to Amanda Psyrri. They discuss her recently published study that aimed to investigate the association of immune cell-related biomarkers in the tumor and tumor microenvironment with PD-1 checkpoint inhibitors’ outcomes in patients with metastatic head and neck squamous cell cancer (HNSCC).”

Read further.
Source: ESMO/LinkedIn